Cardinal Health is trading at $219.21, down 4.49%, after recently disclosed executive stock sales raised selling-pressure concerns.

  • CEO Jason Hollar sold 124,529 shares worth approximately $29.4 million across August 18 and August 19.
  • Chief Legal Officer Jessica Mayer sold 29,436 shares, approximately $7.0 million.
  • The transactions followed the August 11 fiscal 2026 earnings release, despite strong results and fiscal 2027 guidance; no newer earnings announcement or major overnight operating update was found.